Iterum Therapeutics (ITRM) P/E (2020 - 2026)
Iterum Therapeutics (ITRM) P/E from Jun 30, 2020 to Mar 26, 2026. The TTM Iterum Therapeutics (ITRM) P/E is -0.22. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Iterum Therapeutics (ITRM)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.22 | -47.46% |
| 2025 | -0.42 | -68.00% |
| 2024 | -1.30 | +190.11% |
| 2023 | -0.45 | +55.02% |
| 2022 | -0.29 | -97.82% |
| 2021 | -13.25 | +25.08% |
| 2020 | -10.60 | N/A |
Comparison Iterum Therapeutics (ITRM) P/E with competitors
Iterum Therapeutics (ITRM) P/E is -0.22.